Last Updated on January 3, 2024 by The Health Master
Drug recall:
Exela Pharma Sciences, LLC (Exela) is voluntarily recalling 49 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton, to the consumer level.
Risk Statement:
The product poses a potential safety concern with vial breakage and flying glass when pressurized while preparing the product for administration.
Exela has received five (5) reports of flying glass injuring the skin, eye, and/or other parts. There have been no reports of sterility failures.
The product is used for the treatment of metabolic acidosis and is packaged in a 50 mL glass vial, 20 vials per carton.
The vials are labeled with Exela brand (Carton NDC: 51754-5001-5; Vial NDC: 51754-5001-1, Figure 1) and Civica brand (Carton NDC: 72572-740-20; Vial NDC: 72572-740-1, Figure 2).
The affected Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL lots (covering both Exela and Civica brands) include the following lot numbers and expiration dates:
All the above-listed lots are supplied in 20-count cartons only. This recall is not expected to cause a drug shortage.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Drug recall: Acyclovir Sodium Injection recalled due to this reason
Drug recall: Zydus, Lupin recall products due to this issue
Drug recall: Glenmark, Strides Pharma, Cipla recalled these drugs
Drug recall: Glenmark, Sun, Dr Reddy’s recalled these Drugs
Drug recall: Atorvastatin 40 mg tablets recalled due to this reason
Drug recall: Magnesium Citrate Oral Solution recalled due to this reason
CDSCO Panel gives conditional nod for Nimesulide Granules
USFDA issues form 483 with 17 observations to Lupin
Govt notifies rules to exempt certain medical devices under Class A
PCI to implement Pharmacy Practice Regulations, 2015
Drug alert: 59 out of 1456 samples declared as NSQ in September 2022
Govt notifies rules to ease New Drugs and Clinical Trials norms
Govt brings these eight substances under NDPS Act
CDSCO Panel gives nod to study Anti Allergic Combination Drug
DCGI notifies classification of 48 Medical Devices related to Oncology under MDR 2017
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
